Neurothera Labs has been granted a U.S. patent for combining antimicrobials and cannabinoids designed to fortify antibiotics against resistant bacterial strains. The company is a majority-owned subsidiary of SciSparc, is a clinical-stage pharmaceutical company developing therapeutics for central nervous system disorders and other underserved health conditions.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Tilray Brands ignites “Championship Sunday”
2 | MariMed’s Betty’s Eddies introduces new limited-edition Valentine’s seasonal offerings
3 | Aurora Cannabis announces fiscal 2026 Q3 results
4| Independent proxy advisory firms, ISS and Glass Lewis, recommend MTL shareholders vote for the arrangement resolution with Canopy Growth
Top Cannabis Stocks Jan. 31 to Feb. 05, 2026
1. T.CURA | 9,198 views | Curaleaf Holdings Inc.
2. T.TLRY | 2,743 views | Tilray Brands Inc.
3. T.LABS | 1,984 views | Medipharm Labs Corp.
4. C.TGIF | 539 views | 1933 Industries Inc.
5. T.OGI | 340 views | Organigram Global Inc.
6. T.ACB | 336 views | Aurora Cannabis Inc.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
